Evers R, Zaman G J, van Deemter L, Jansen H, Calafat J, Oomen L C, Oude Elferink R P, Borst P, Schinkel A H
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
J Clin Invest. 1996 Mar 1;97(5):1211-8. doi: 10.1172/JCI118535.
The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S-conjugate S-(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1-transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance.
人类多药耐药相关蛋白MRP通过降低细胞内药物浓度赋予对多种细胞毒性药物的抗性。最近的证据表明,MRP还能跨膜转运谷胱甘肽S-共轭物。为了研究MRP在完整细胞中的转运特性,我们已在极化的猪肾上皮细胞系LLC-PK1中表达了人类MRP cDNA。通过共聚焦激光扫描免疫细胞化学和电子显微镜确定,MRP主要定位于这些细胞的基底外侧质膜,而非顶端膜。与这种定位一致,MRP导致谷胱甘肽S-共轭物S-(2,4-二硝基苯基)-谷胱甘肽和抗癌药物柔红霉素向上皮细胞层基底侧的转运增加。已知的多特异性有机阴离子转运抑制剂磺吡酮和丙磺舒抑制这种基底外侧转运,但不抑制由顶端定位的人类MDR1 P-糖蛋白介导的柔红霉素在MDR1转染的LLC-PK1细胞中的顶端转运。因此,丙磺舒和磺吡酮可能是开发针对MRP介导的耐药性的临床逆转剂的有用先导化合物。